Work

Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (Crizotinib, PF02341066) in an ALK Translocation-Positive Patient with Non-small Cell Lung Cancer

Year: 2010

Type: article

Study design: Case Report

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e318200f9ff

Authors: Sai-Hong Ignatius Ou, Lyudmila Bazhenova, D. Ross Camidge, Benjamin J. Solomon, June Herman, Tatiana Kain, Yung-Jue Bang, Eunice L. Kwak, Alice T. Shaw, Ravi Salgia, Robert G. Maki, Jeffrey W. Clark, Keith D. Wilner, A. John Iafrate

Institutions: University of California, Irvine Medical Center, UC Irvine Chao Family Comprehensive Cancer Center, University of California San Diego Medical Center, Moores Cancer Center, University of Colorado Cancer Center, Peter MacCallum Cancer Centre, Seoul National University, Seoul National University Hospital, Massachusetts General Hospital, University of Chicago Medical Center, Memorial Sloan Kettering Cancer Center, Pfizer (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2080903186

FWCI: 10.81

Cites: 7

Cited by: 77

Related to: 10